The nation of Zimbabwe has declined a significant American health deal valued at 367 million US dollars (£272m) over five years due to Washington's insistence on sensitive information.
This move came to light after a official document from December was disclosed, which showed President Emmerson Mnangagwa deemed the deal was "unbalanced".
An official spokesperson has since clarified that the US was seeking biological samples for scientific study and commercial purposes while was unwilling to guarantee the benefits from any future treatments.
"We are forced to start the difficult and regrettable process of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for more talks to find a agreement acceptable to all parties so the nation's critical HIV programme can proceed.
Broader Background
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a court blocked a related deal with the US after concerns were raised about the security of citizens' medical information.
After returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
USAID had overseen aid for the US government, but Trump stated its expenditure was "wasteful" and his administration was seeking government-to-government agreements to enhance openness and accountability.
Based on reports, Sixteen African countries have to date agreed to similar agreements, representing over $18.3bn of fresh investment.
Details of the Rejected Deal
The funds for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded initiatives," Tremont said.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, without any equivalent assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that could result from that shared data," his statement read.
"In essence, our country would supply the raw materials for scientific discovery with no certainty that the final treatments would be available to our citizens if a new health crisis emerge."
Sovereignty and Global Health
He also noted that the American exit from the global health body and its pursuit of one-on-one deals were disrupting structures already set up through the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to manage potential global health emergencies.
"This framework is designed to ensure that when a country contributes its data, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the funds to create them."
These objections regarding the US deal "are not meant as anti-American sentiment," he added.
"We are open to further discussions with our US partners on how subsequent collaboration could be arranged in a way that respects the independence and dignity of both nations."
Medical Community Reaction
A leading public health body expressed it understood the government's concerns, but recommended that talks need to persist given that much of the nation's Aids initiatives were funded by external financing.
"Where technical issues exist, such as those involving information security or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," it commented.
The situation emphasises the continuing tensions between receiving vital international aid and protecting a country's data in an ever more interconnected world.